000 | 01235 a2200325 4500 | ||
---|---|---|---|
005 | 20250514033904.0 | ||
264 | 0 | _c20020701 | |
008 | 200207s 0 0 eng d | ||
022 | _a0006-4971 | ||
024 | 7 |
_a10.1182/blood-2002-02-0624 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aDevine, Steven M | |
245 | 0 | 0 |
_aReduced duration of cytopenias following melphalan conditioning and autografting for multiple myeloma. _h[electronic resource] |
260 |
_bBlood _cJun 2002 |
||
300 |
_a4251-2; author reply 4252 p. _bdigital |
||
500 | _aPublication Type: Comment; Letter | ||
650 | 0 | 4 | _aCombined Modality Therapy |
650 | 0 | 4 |
_aHematopoietic Stem Cell Transplantation _xadverse effects |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 |
_aMelphalan _xtherapeutic use |
650 | 0 | 4 |
_aMultiple Myeloma _xdrug therapy |
650 | 0 | 4 |
_aNeutropenia _xprevention & control |
650 | 0 | 4 |
_aThrombocytopenia _xprevention & control |
650 | 0 | 4 | _aTransplantation, Autologous |
650 | 0 | 4 | _aWhole-Body Irradiation |
700 | 1 | _aJahagirdar, Balkrishna | |
700 | 1 | _avan Besien, Koen | |
773 | 0 |
_tBlood _gvol. 99 _gno. 11 _gp. 4251-2; author reply 4252 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1182/blood-2002-02-0624 _zAvailable from publisher's website |
999 |
_c11940365 _d11940365 |